Mini-transplant and imatinib mesylate were temporarily effective in a patient with ph1 positive acute lymphoblastic leukemia which had been refractory to conventional chemotherapy
        山口医学 Volume 51 Issue 6
        Page 193-198
        
    published_at 2002-12-31
            Title
        
        ミニ移植およびImatinib Mesylateが一時的に有効であった化学療法不応性フィラデルフィア染色体陽性急性リンパ性白血病の1症例
        Mini-transplant and imatinib mesylate were temporarily effective in a patient with ph1 positive acute lymphoblastic leukemia which had been refractory to conventional chemotherapy
        
    
                
                    Creators
                
                    Tominaga Takayuki
                
                
            
            
            
                
                    Creators
                
                    Nakamori Yoshitaka
                
                
            
            
                
                    Creators
                
                    Shimohakamada Yoko
                
                
            
            
                
                    Creators
                
                    Taguchi Akihiko
                
                
            
            
                
                    Creators
                
                    Miyazaki Mutsuko
                
                
            
            
                
                    Creators
                
                    Shinohara Kenji
                
                
            
    
        
            Source Identifiers
        
    
    
            Creator Keywords
        
            Ph1陽性ALL
            ミニ移植
            Imatinib Mesylate
    Mini-transplant was performed in a patient with Philadelphia chromosome (Ph1) positive acute lymphoblastic leukemia (ALL) which had been refractory to repeated courses of chemotherapy. Decrease of leukemic cells and mixed chimerism were observed during a first month. However, leukemic cells increased thereafter, and donor leukocyte infusion(DLI) was ineffective. Subsequently, Imatinib Mesylate was administered and leukemic cells decreased for 2 months, however lekemic cells increased thereafter. These treatments were temporarily effective for Ph1 positive ALL which was refractory to conventional chemotherapy. The improvement of these treatment strategies and accumulation of these cases are necessary.
        
        
            Languages
        
            jpn
    
    
        
            Resource Type
        
        journal article
    
    
        
            Publishers
        
            山口大学医学会
    
    
        
            Date Issued
        
        2002-12-31
    
    
            Rights
        
            本文データは山口大学医学会の許諾に基づきCiNiiから複製したものである()
    
        
            File Version
        
        Version of Record
    
    
        
            Access Rights
        
        open access
    
    
            Relations
        
            
                
                
                [ISSN]0513-1731
            
            
                
                
                [NCID]AN00243156
            
            
                [isVersionOf]
                
                [NAID]http://ci.nii.ac.jp/naid/110002773756/
            
    
